|
|||||
|
|
Effects of briakinumab treatment for moderate to severe psoriasis on health‐related quality of life and work productivity and activity impairment: results from a randomized phase III study |
|
| Authors: | K.A. Papp M. Sundaram Y. Bao D.A. Williams Y. Gu J.E. Signorovitch Y. Wang J.M. Valdes P.M. Mulani |
| Affiliation: | 1. Probity Medical Research, , Waterloo, Ontario, Canada;2. AbbVie Inc., , North Chicago, Illinois, USA;3. Analysis Group, , Boston, Massachusetts, USA |
| Abstract: | |
| Keywords: | |